Public annual accounts

Dr. Jozefien Roose financials

A multi-period view of the public annual-account figures reported for Dr. Jozefien Roose, with comparable measures and links to available source documents.

Company overview
Registry number

0795265881

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€168,446

+95.1%

EBITDA
€167,816

+94.8%

Total assets
€275,782

+113.6%

Equity
€238,459

+118.9%

EBITDA margin +99.6% · Equity ratio +86.5%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€168,446€167,816€275,782€238,459-
202431 Dec 2024€86,344€86,154€129,137€108,939-
Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report
Dr. Jozefien Roose financials and annual accounts | Upswitch